23.10.2014 Views

Firstly, Lion Capital acquired eyewear retailer Alain Afflelou - Unquote

Firstly, Lion Capital acquired eyewear retailer Alain Afflelou - Unquote

Firstly, Lion Capital acquired eyewear retailer Alain Afflelou - Unquote

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

34<br />

unquote.com/funds<br />

Idinvest launches mezzanine fund<br />

Mid-market European private equity<br />

firm Idinvest Partners has launched the<br />

Idinvest Private Value Europe fund.<br />

The vehicle will focus on mezzanine<br />

investments in mid-market European<br />

companies, but will also target the<br />

secondaries market.<br />

The fund will primarily target<br />

institutional and private investors, but retail<br />

investors are also able to invest in the vehicle<br />

as a result of an agreement granted by the<br />

French securities regulator.<br />

Non-sophisticated investors will be<br />

sourced from the network at Oddo & Cie<br />

investment bank.<br />

The fund has a target of €150m and will<br />

focus on mezzanine investments in midmarket<br />

companies, aiming to see returns<br />

EDF sponsors new cleantech VC fund<br />

Idinvest Private Value Europe<br />

Target €150m<br />

Announced April 2012<br />

Focus<br />

Mezzanine<br />

Fund manager Idinvest Partners<br />

of 10%. The fund will also invest in the<br />

secondaries market.<br />

Electranova <strong>Capital</strong><br />

French energy company EDF has<br />

partnered with private equity house Idinvest<br />

Partners to launch cleantech venture capital<br />

fund Electranova <strong>Capital</strong>.<br />

The fund has already raised €40m<br />

and will be managed independently by<br />

Idinvest Partners.<br />

EDF committed €30m to the project<br />

while Allianz, the first institutional LP to<br />

invest in the vehicle, contributed €10m.<br />

The search for investors will continue<br />

throughout 2012 and discussions with<br />

several potential LPs are already underway.<br />

Electranova will finance start-ups active<br />

in the energy sector, both in France and<br />

Europe, via minority shareholdings.<br />

Target €100m<br />

Announced May 2012<br />

Closed on €40m first close, May 2012<br />

Focus<br />

Cleantech venture<br />

Fund manager Idinvest Partners<br />

123Venture launches €100m<br />

French mezzanine fund<br />

123Venture has launched a new<br />

mezzanine fund, Trocadero <strong>Capital</strong> &<br />

Transmission II, with a €100m target.<br />

The FCPR will be operated by<br />

123Venture’s new arm Trocadero <strong>Capital</strong>,<br />

which was launched to focus on institutional<br />

investors while 123Venture mainly manages<br />

retail vehicles.<br />

123Venture will commit €7m to the fund,<br />

while the remainder will be provided by<br />

institutional clients.<br />

Trocadero <strong>Capital</strong> & Transmission II will<br />

Cross Road holds first close on €30m<br />

Trocadero <strong>Capital</strong> & Transmission II<br />

Target €100m<br />

Announced May 2012<br />

Focus<br />

Mezzanine, France<br />

Fund manager Trocadero <strong>Capital</strong><br />

provide mezzanine funding to French SMEs.<br />

Philippe Bruneau will manage the fund for<br />

123Venture.<br />

CRB Bio II<br />

Cross Road Biotech has announced the<br />

first closing of its second fund, CRB Bio II,<br />

on €30m.<br />

The fund has a target of €60m, which it<br />

aims to reach in the coming months. The<br />

vehicle was launched in October 2010.<br />

<strong>Capital</strong> commitments originate from<br />

private and public investors.<br />

The fund will invest in 10-12 SMEs in<br />

the biomedical sector, targeting the therapy,<br />

medical and alimentary products industries<br />

over a period of eight years.<br />

Target €60m<br />

Announced October 2010<br />

Closed on €30m, April 2012 (first close)<br />

Focus<br />

Biomedicine<br />

Fund manager Cross Road Biotech<br />

Issue 5 – June 2012

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!